News
-
-
PRESS RELEASE
EQS-Adhoc: PAUL Tech AG: Approval of decision to refinance existing EUR 35m 7% 2020/2025 bond through Issue of a Nordic bond
PAUL Tech AG approves to refinance existing EUR 35m 7% 2020/2025 bond through issuance of Nordic bond. Pareto Securities & B. Metzler appointed as coordinators. Market launch today -
-
-
-
PRESS RELEASE
Press Release: EADV: Sanofi’s brivekimig achieved positive results in hidradenitis suppurativa in phase 2a study
Sanofi's brivekimig shows positive results in phase 2a study for hidradenitis suppurativa, presenting clinically meaningful improvements in primary and secondary endpoints in biologic-naïve patients -
-
-
PRESS RELEASE
Horus Pharma becomes additional commercialization partner for Formycon's Eylea® biosimilar FYB203 in selected European countries under the brand name Baiama®
Horus Pharma partners with Formycon for Eylea biosimilar commercialization in Europe under Baiama brand. Agreement includes upfront payments and royalties for Klinge. Aflibercept treats nAMD -